External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Retina Society 2022
Roche and Genentech at

Retina Society 2022

November 02 - November 05
Pasadena, USA
retinasociety.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
04:12 PM
Duration 6mins Huntington Ballroom
Efficacy, Durability, and Safety of Faricimab in Diabetic Macular Edema: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Khurana R, Wells J, Baumal C, Danzig C, Murata T, Schlottmann P, Lin H, Mohan S, Silverman D, Tang Y, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:45 AM
Duration 3mins Huntington Ballroom
Design and Rationale of Elevatum: A Phase 4 Trial of Faricimab (VABYSMO) in Underrepresented Patients With Diabetic Macular Edema
Scott A, Amador M, Chang J, Yang M, Stoilov I, Meldorf M, Coney J, Gonzalez L, Cunningham M
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:38 AM
Duration 4mins Huntington Ballroom
Increased Central Foveal Thickness Fluctuations are Associated with Less Visual Gains in Patients With Central Retinal Vein Occlusion
Kuriyan A, Chiang A, Regillo C, Yonekawa Y, Ho A, Hsu J, Garg S, Yankovskaya Y, Blotner S, Stoilov I, Starr M
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:13 AM
Duration 8mins Huntington Ballroom
Efficacy, Safety, and Durability of Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Results From the Phase 3 TENAYA and LUCERNE Trials
Lim J, Silverman D, Swaminathan B, Patel V, Lin H, Willis J, Kotecha A
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:21 AM
Duration 3mins Huntington Ballroom
Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Patient Case Profiles From the Phase 3 TENAYA and LUCERNE Trials
London N, Pearce, I, Figueroa MS, Silverman D, Swaminathan B, Patel V, Lin H, Willis JR, Kotecha A
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:30 AM
Duration 4mins Huntington Ballroom
Overview of Faricimab safety profile from the four Phase 3 studies in nAMD and DME through 2 years
Jaffe G, Kardatzke D, Kotecha A, Steeples L, Willis J, Ives J
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:34 AM
Duration 4mins Huntington Ballroom
Intraocular Suppression of VEGF-A and Ang-2 Following Intravitreal Administration of Faricimab
Avery R, Stoilov I, Bogman K, Diack C
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:42 AM
Duration 4mins Huntington Ballroom
Supplemental Intravitreal Ranibizumab Injections in Patients With the Port Delivery System With Ranibizumab in the Phase 3 Archway Trial for Neovascular Age-Related Macular Degeneration
Pieramici D, Gune S, DeGraaf S, Barteselli G, Heinrich D
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:56 AM
Duration 4mins Huntington Ballroom
Key Pearls of the Refill-Exchange Procedure for the Port Delivery System With Ranibizumab
Dhoot D, Khanani A, Singh N, Barteselli G, Callaway N, Patel S, Jaycock PD, Malhorta V, Menezes A
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:17 PM
Duration 5mins Huntington Ballroom
Personalized Treatment Interval Dosing Dynamics Over 2 Years in the Phase 3 YOSEMITE/RHINE Trials of Faricimab in Diabetic Macular Edema
Steinle NC, Jaffe GJ, Gerendas BS, Chakravarthy U,Goldberg RA, Korobelnik JF, Tan CS, Abreu F, Jain N, Tang Y, Camino A, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.